| Q52385030 | A multivariate analysis of anatomic success of retinal detachments treated with scleral buckling. |
| Q48896311 | An endoscopic overview of the anterior vitreous base in retinal detachment and anterior proliferative vitreoretinopathy |
| Q41866514 | An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy. |
| Q78206035 | Cell adhesion molecules in subretinal fluid: soluble forms of VCAM-1 (vascular cell adhesion molecule-1) and L-selectin |
| Q37080418 | Clinical and surgical risk factors in the development of proliferative vitreoretinopathy following retinal detachment surgery: a systematic review protocol |
| Q64087619 | Comparative study of endolaser versus cryocoagulation in vitrectomy for rhegmatogenous retinal detachment |
| Q73025091 | Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose |
| Q44301466 | Edible mushroom (Agaricus bisporus) lectin modulates human retinal pigment epithelial cell behaviour in vitro |
| Q41146490 | Exclusive Use of Air as Gas Tamponade in Rhegmatogenous Retinal Detachment. |
| Q39579160 | Inflammation and the formation of epiretinal membranes |
| Q42004413 | Intravitreal and subretinal proliferation induced by platelet-rich plasma injection in rabbits. |
| Q36980716 | Involvement of STIM1 and Orai1 in EGF-mediated cell growth in retinal pigment epithelial cells |
| Q40662604 | Is surgery for proliferative vitreoretinopathy justifiable? |
| Q69515102 | Pars plana vitrectomy in aphakic and pseudophakic retinal detachment |
| Q39017048 | Pathological vitreous causes cell line-derived (but not donor-derived) retinal pigment epithelial cells to display proliferative vitreoretinopathy-like features in culture |
| Q45197233 | Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? |
| Q72853499 | Primary vitrectomy for rhegmatogenous retinal detachment |
| Q77144020 | Proliferative vitreoretinopathy: an overview |
| Q43782531 | Retinal break type and proliferative vitreoretinopathy in nontraumatic retinal detachment |
| Q74429379 | Risk factors for proliferative vitreoretinopathy |
| Q24673031 | Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study |
| Q44126288 | Role of daunorubicin in inhibiting proliferative vitreoretinopathy after retinal detachment surgery |
| Q34724425 | Simple retinal detachments: identifying the at-risk case |
| Q37295525 | The chemoattractant activity of the vitreous to human scleral fibroblasts following retinal detachment and proliferative vitreoretinopathy |
| Q68466722 | The development of severe proliferative vitreoretinopathy after retinal detachment surgery. Grade B: a determining risk factor |
| Q46923094 | The role of inflammation in the development of epiretinal membranes |
| Q73345121 | The role of retinotomy in an experimental rabbit model of proliferative vitreoretinopathy |